TDVXF (TDVXF) Stock Price & Analysis
TDVXF (TDVXF) rose 10.56% to USD 8.9 as of June 10, 2026 at 05:37 UTC, according to Nexqual real-time market data.
TDVXF last closed at USD 8.05; the session ranged USD 8.9–8.9 on volume of 200 shares. Market capitalization is $939.42M, with a 52-week range of USD 7.9–13.55 (PNK). Source: Nexqual, June 10, 2026 at 05:37 UTC.
Key Statistics (as of June 10, 2026 at 05:37 UTC)
| Price | USD 8.9 |
|---|---|
| Change | ▲ 10.56% (up) |
| Previous Close | USD 8.05 |
| Open | USD 8.9 |
| Day Range | USD 8.9 – 8.9 |
| 52-Week Range | USD 7.9 – 13.55 |
| Volume | 200 shares |
| Market Cap | $939.42M |
| Exchange | PNK |
Technical Analysis (TDVXF)
Nexqual's technical model rates TDVXF "SELL" based on 1 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 05:37 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 33.62 (neutral) |
| vs SMA50 | Below (USD 8.98) |
| MACD | -0.24 (negative) |
Analyst Ratings (TDVXF)
Wall Street analysts rate TDVXF "None", per Nexqual as of June 10, 2026 at 05:37 UTC.
| Consensus Rating | None |
|---|
Earnings (TDVXF)
| Next Earnings Date | 2026-07-22 |
|---|---|
| Revenue Estimate | $687.25M |
Source: Nexqual, June 10, 2026 at 05:37 UTC.
Financials & Fundamentals (TDVXF)
| Revenue Growth (YoY) | +1.20% |
|---|---|
| Gross Margin | +68.24% |
| Operating Margin | +0.00% |
| Profit Margin | +7.26% |
| ROE | +32.49% |
| Debt / Equity | 167.12 |
| Current Ratio | 1.63 |
| Free Cash Flow | $31.54M |
Source: Nexqual, June 10, 2026 at 05:37 UTC.
Financial Health Score (TDVXF)
Nexqual rates TDVXF's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 05:37 UTC.
| Growth | Strong — Revenue +25% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 68%, operating 0% |
| Balance Sheet | Weak — Debt/Equity 1.7x |
| Cash Flow | Mixed — FCF $32M, slim 1.3% margin |
| Efficiency | Strong — ROE 32%, ROA 8.6% |
Ownership (TDVXF)
| Insider Ownership | +4.12% |
|---|---|
| Institutional Ownership | +75.61% |
| Shares Outstanding | 105.55M |
| Float | 100.91M |
Source: Nexqual, June 10, 2026 at 05:37 UTC.
Leadership (TDVXF)
TDVXF is led by Fredrik Ruben (age 48), Chief Executive Officer, per Nexqual as of June 10, 2026 at 05:37 UTC.
| Chief Executive Officer | Fredrik Ruben (age 48) |
|---|---|
| Chief Financial Officer | Linda Tybring (age 49) |
| Chief Operating Officer | Luis Mustafa (age 47) |
| Corporate Communications Director | Elisabeth Manzi |
| Chief Marketing Officer | Kristen Cook (age 46) |
Major Backers & Investors (TDVXF)
Notable institutional backers of TDVXF include SmallCap World Fund Inc, American Century ETF Trust-Avantis International Small Cap Value ETF, Fidelity, according to Nexqual as of June 10, 2026 at 05:37 UTC.
Active Investors
| Investor | Stake |
|---|---|
| SmallCap World Fund Inc | 4% |
| American Century ETF Trust-Avantis International Small Cap Value ETF | 1.96% |
| Fidelity | 0.26% |
| WASATCH FUNDS TRUST-Wasatch International Growth Fund | 0.18% |
| DFA INVESTMENT DIMENSIONS GROUP INC-Intl Core Eqy. 2 PORT. | 0.16% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 1.12% |
| Dimensional Fund Advisors | 0.36% |
Source: Nexqual, June 10, 2026 at 05:37 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SARTF | Sartorius AG | USD 217.65 | ▲ 0% |
| CNVVY | ConvaTec Group plc | USD 10.79 | ▼ 1.91% |
| SDMHF | Sartorius Stedim Biotech | USD 212.25 | ▲ 0.59% |
| ANSLY | Ansell Ltd. | USD 78.77 | ▲ 5.9% |
| SHWGY | Shandong Weigao Group Medical P | USD 2.19 | ▲ 25.86% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 05:37 UTC. This page is informational and not investment advice.